California CNS advisory committee debates requiring national certification and oversight of CNS programs

Members of the Board of Registered NursingClinical Nurse Specialist Advisory Committee on Aug. 27 discussed draft regulatory language addressing licensure pathways, national certification, and oversight of CNS education but took no formal regulatory vote.

The committee heard public comment and a presentation from the California Association of Clinical Nurse Specialists (CACNS) on advocacy for "full practice authority," and staff from the BRN described the multi-step regulatory review process and limits set by state statute.

Loretta (BRN executive officer) told the committee that the board "has directed us to align with the consensus model," but she emphasized that current California statute limits the CNS role: "right now, the CNS has the scope of practice of an RN even though they are an APRN," and therefore the state does not yet provide an expanded APRN scope of practice for CNSs.

Terry Arris, director of the clinical nurse specialist program at California State University, Dominguez Hills, urged caution about adding oversight requirements. She said CNS programs "have been in decline for the last 15 years" and warned that additional, burdensome state regulation could further reduce program availability. "I just wanna urge the committee to be cautious in how they decide to require any oversight," she said.

Mary Launson Nichols, president of the California Association of Clinical Nurse Specialists, described CACNSefforts to win practice authority for CNSs and said the group began an advocacy initiative in 2024. "We started this process in 2024 and CACNS has, formally launched its initiative to secure practice authority for CNSs in California," she said, outlining goals that include independent practice and prescriptive authority for master nd doctoral-prepared CNSs.

Committee members and staff discussed three broad regulatory approaches: require national certification for licensure; defer to national accreditation of academic programs (as is done for some APRN roles); or adopt a hybrid that requires certification but allows a time-limited temporary permit for new graduates. Loretta described existing pathways used elsewhere: "Kansas ... allow[s] for a temporary ... license on graduation for completion of an accredited program and gave that person six months to obtain national certification." She said whether BRN can adopt similar language depends on whether the board has statutory authority.

Alyssa Brown, vice chair of the advisory committee and a longtime CNS, voiced support for national certification: "I think my thought would be just to go for national cert." Lizzie Scribe, who identified herself as an executive director at Kaiser Permanente, also said she favored requiring national certification and oversight of program quality, citing concerns about program variation and student outcomes.

Staff described current BRN practice: California permits two licensure pathways for CNSs in-state (a board-approved in-state program pathway and a national-certification pathway). The board does initial reviews of in-state programs ("method 1") but does not conduct routine, ongoing program surveillance of outcomes such as national exam pass rates, attrition, graduation or faculty sufficiency. BRN staff and legal counsel urged the committee to weigh whether oversight should be limited to reporting outcome metrics or should more closely follow the nurse practitioner model, which prescribes specific program and faculty requirements in regulation.

Committee members also discussed workforce and regulatory consequences. Terry and other speakers said some CNS national certification exams are no longer offered in all population foci, a factor that complicates any strict certification-only pathway. Several members supported the idea of a limited interim permit so graduates can begin practice while they complete national certification; BRN staff said an interim permit model already exists for pre-licensure RNs (six months while awaiting NCLEX) and could be adapted if statutory authority permits.

BRN staff outlined the formal regulatory path: internal legal review, Department of Consumer Affairs regulatory counsel review, possible Office of Administrative Law review, a public comment period during which the agency must respond to every comment, and the possibility of additional rounds of revision. They also warned that regulations cannot expand statutory authority and that any change that effectively grants CNSs an expanded APRN scope would likely require legislation.

The committee did not vote on any regulatory text at the meeting. Members directed the regulatory subcommittee to continue meetings and to draft proposals for the committee to consider, including options for temporary permits, certification requirements, and the degree of academic oversight. The BRN said draft regulatory language and supporting materials will be posted for committee review and public comment ahead of future meetings.

Why this matters: changes could affect how quickly newly graduated CNSs may begin clinical work, whether CNS programs in California remain viable, and whether CNSs in the state eventually gain independent practice or prescribing authority.

Next steps: the regulatory subcommittee will meet to develop options for the full advisory committee and to prepare draft language for public posting and legal review. The BRN encouraged stakeholders to submit written comments and offered to accept additional input by email or through the subcommittee process.